Medical cannabis is not a recommended treatment for glaucoma. Smoking or vaping THC can lower intraocular pressure for roughly three to four hours, but the drop is modest, the effect wears off quickly, and there is no evidence that cannabis protects the optic nerve or preserves vision. The American Academy of Ophthalmology and the American Glaucoma Society both advise patients to use proven prescription therapies rather than marijuana.

Does medical cannabis lower eye pressure?

Yes, temporarily. A 1971 study by Hepler and Frank first reported that smoked marijuana reduced intraocular pressure in healthy volunteers, and later research confirmed that THC, the main psychoactive compound in cannabis, can lower pressure by about 20 to 25 percent in some users.

The effect peaks within an hour or two and fades by hour four. That short window is the core problem for glaucoma care, which needs pressure control around the clock.

CBD behaves differently. Some studies suggest that isolated cannabidiol can slightly raise intraocular pressure rather than lower it, so CBD-dominant products are not a substitute for THC in this context.

Why don't eye doctors recommend cannabis for glaucoma?

How much cannabis would a glaucoma patient need?

Researchers have estimated that maintaining a meaningful pressure reduction would require smoking cannabis roughly every three hours, including through the night, or about six to eight doses per day.

That schedule is impractical for most people. It also produces sedation, impaired coordination, memory problems, and possible dependency, which make it unsafe for driving or working.

What treatments actually work for glaucoma?

Prescription eye drops are the standard first step. Prostaglandin analogs such as latanoprost lower pressure about 25 to 33 percent with a single nightly dose, while beta blockers, alpha agonists, and carbonic anhydrase inhibitors offer additional options.

When drops are not enough, doctors use laser trabeculoplasty, selective laser trabeculoplasty, or surgical procedures such as trabeculectomy and drainage implants. These approaches have decades of evidence showing they slow optic nerve damage.

Are cannabis-based eye medicines coming?

Scientists continue to study cannabinoid receptors in the eye and possible topical formulations. However, no cannabis-derived eye drop has been approved by the FDA for glaucoma, and any future product would need to outperform existing drops on both efficacy and safety.

What should patients ask their eye doctor?

Ask whether your current intraocular pressure is at target, how often you should be monitored, and what options exist if drops cause side effects or are hard to tolerate. Tell your ophthalmologist about any cannabis, CBD, or herbal product you use, since these can interact with other medications and affect blood pressure.

Key takeaways